Skip to main content



Local Cdiff information for Massachusetts

Massachusetts

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Massachusetts.



Local Cdiff information for Massachusetts

Massachusetts

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Massachusetts.

Providers


Dr. Alan C. Moss, MD,

FACG, FEBG
Interim Chief, Department of Gastroenterology
Boston Medical Center
725 Albany Street, 6th Floor
Boston02118
(617) 638-6525
FMT Provider: Yes

Dr. Stacy A. Kahn, MD

Director, Fecal Microbiota Transplantation; Attending Physician, Division of Gastroenterology, Hepatology and Nutrition
Boston Children’s Hospital
300 Longwood Avenue
Boston02115
617-355-6058
FMT Provider: Yes

Dr. Razvan Arsenescu, MD, PhD

90 Libbey Industrial Parkway
Weymouth02189
781-682-0630
FMT Provider: Yes

Regulation


C. diff Infections

Total Reported Cases: 2115
Hospital Onset: 2115
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.78

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: Yes
LTC Facility Data Publicly Reported: No
Law/Regulation: MGL. c .111D, s. 6

State Contact

Eileen McHale
Patient Safety Ombudsman
Massachusetts Department of Public Health
Betsy Lehman Center for Patient Safety and Medical Error Reduction
99 Chauncy Street
Boston, 2111
(617) 753-7324

CLINICAL TRIALS


Xylitol Use for Decolonization of C. Difficile in Patients With IBD

Official Title: Xylitol Use for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease
Trial No. NCT05852587
Type: Interventional
Recruitment: Not Yet Recruiting
Sponsor: Brigham and Women’s Hospital
Contact: Emma McClure
617-732-9223
Gender: All
Age: 18 Years and older

Outcomes and Data Collection for FMT

Official Title: Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
Trial No. NCT03562741
Type: Interventional
Recruitment: Recruiting
Sponsor: Kruna Patel, University of Massachusetts, Worcester
Contact: Anne Foley
Gender: All
Age: 16 years and older

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
Gender: All
Age: All ages

OpTION

Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
Gender: All
Age: 18 Years and older

ICON-2

Official Title: A Randomized Controlled Trial to Compare the Effectiveness of Fecal Microbiota Transplantation (FMT) in Combination With Bezlotoxumab Compared to FMT and Placebo for the Prevention of CDI Recurrence in Patients With Inflammatory Bowel Disease and Recurrent Clostridium Difficile Infection
Trial No. NCT03829475
Type: Interventional
Recruitment: Recruiting
Sponsor: Brigham and Women’s Hospital
Contact: Emma McClure
617-525-7322
Gender: All
Age: 18 Years and older

ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
Gender: All
Age: 18 Years and older